TipRanks
Go Ultimate55% OFF

Care Twentyone Corporation (2373) AI Stock Analysis

Top Page

JP:2373

Care Twentyone Corporation

(TSE/TYO:2373)

Select Model
Rating:52Neutral
Price Target:JPY 395.00â–²(1.02% Upside)
Action:reiterated
Date:09/15/26

The overall score of 52 reflects a balance of positive cash flow and technical momentum against significant balance sheet risk. The company's high leverage is the most significant factor weighing on the score, offsetting strong cash conversion and a decent dividend yield. The stock's recent price strength is tempered by overbought technical signals.

Positive Factors
Revenue GrowthSustained revenue expansion, including a sharper acceleration in 2025, indicates improving demand and market reach. Continued top-line growth can support operating leverage, provide resources for reinvestment, and strengthen the company’s ability to absorb moderate cost pressure over the coming quarters.
Negative Factors
High LeverageDebt-to-equity above 4x materially reduces financial flexibility and makes results more sensitive to interest-rate changes or weaker operating performance. High leverage can absorb a larger share of future cash flow through financing needs, limiting room for investment and resilience during downturns.

Care Twentyone Corporation (2373) vs. iShares MSCI Japan ETF (EWJ)

-15%-10%-5%0%5%10%15%20%25%JP:2373-11.67%EWJ+15.87%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
JPY 5.29B
Dividend Yield
4.35%
Average Volume (3M)
14.41K
Price to Earnings (P/E)
18.4
Beta (1Y)
0.27
Revenue Growth
4.76%
EPS Growth
-52.55%
Country
Japan
Employees
6,319
Sector
Healthcare
Sector Strength
51
Industry
Medical - Care Facilities

Care Twentyone Corporation Business Overview & Revenue Model

Company Description

Care Twentyone Corporation operates as a comprehensive welfare company in Japan. The company offers home care, paid nursing home, dementia group home, in-home care support, small-scale multi-functional home care, day service, and welfare equipment re...

Care Twentyone Corporation Financial Statement Overview

Summary

Financial performance is mixed. Cash flow is strong (Score 70), but the balance sheet is weak (Score 20) due to high leverage, and income statement profitability is low (Score 40). The overall financial health is constrained by significant financial risk.

Income Statement

40Negative

Balance Sheet

20Very Negative

Cash Flow

70Positive
Financial statement breakdown
BreakdownTTMOct 2025Oct 2024Oct 2023Oct 2022Oct 2021
Income Statement
Total Revenue49.98B48.16B45.40B41.10B38.40B36.36B
Gross Profit12.10B10.62B9.19B8.61B8.97B8.51B
EBITDA2.71B2.17B937.91M1.20B2.58B2.91B
Net Income287.66M384.18M278.42M6.16M630.49M937.08M
Balance Sheet
Total Assets31.17B32.09B32.94B32.88B36.38B37.60B
Cash, Cash Equivalents and Short-Term Investments4.50B4.17B3.08B2.61B1.88B2.83B
Total Debt18.32B18.55B19.49B18.34B22.51B22.96B
Total Liabilities26.42B27.60B28.21B27.36B29.90B30.83B
Stockholders Equity4.65B4.42B4.71B5.50B6.46B6.77B
Cash Flow
Free Cash Flow2.02B2.02B-367.10M630.16M349.82M1.58B
Operating Cash Flow2.17B2.17B709.85M2.14B1.11B2.61B
Investing Cash Flow139.26M139.26M-1.02B-2.60B-1.39B-1.38B
Financing Cash Flow-1.20B-1.20B782.01M1.20B-679.93M-1.33B

Care Twentyone Corporation Technical Analysis

Technical Analysis SentimentNegative
Last Price391.00

Price Trends

50DMA411.54Negative
100DMA404.62Negative
200DMA409.52Negative

Market Momentum

MACD-5.17Positive
RSI37.13Neutral
STOCH-9.81Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2373, the sentiment is Negative. The current price of 391.00 is below the 20-day moving average (MA) of 410.39, below the 50-day MA of 411.54, and below the 200-day MA of 409.52, indicating a bearish trend. The MACD of -5.17 indicates Positive momentum. The RSI at 37.13 is Neutral, neither overbought nor oversold. The STOCH value of -9.81 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:2373.

Care Twentyone Corporation Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

JP:2373 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:9220JP:922073OutperformJPY 3.19B7.21―3.29%5.48%13.46%
JP:6062JP:606270OutperformJPY 44.61B11.04―3.14%5.16%37.79%
JP:2425JP:242556NeutralJPY 2.50B29.59―3.34%-5.72%-73.78%
JP:2373JP:237352NeutralJPY 5.26B18.40―4.35%4.76%-52.55%
JP:7362JP:736252NeutralJPY 1.30B8.93――14.48%71.76%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%

* Healthcare Sector Average

Performance Comparison

-20%0%20%40%JP:2373JP:2425JP:6062JP:7362JP:9220Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
JP:2373 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:2373Care Twentyone Corporation391.00-67.03-14.63%
JP:2425Care Service Co., Ltd.658.00-120.64-15.49%
JP:6062Charm Care Corporation1368.00313.2729.70%
JP:7362Terminalcare Support Institute, Inc.850.0030.033.66%
JP:9220FB CARE SERVICE CO.,LTD.1308.0086.907.12%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 15, 2026